MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

December 8, 2020

MHRA Authorizes Pfizer, BioNTech COVID-19 Vaccine

The U.K.'s Medicines & Healthcare Products Regulatory Agency (MHRA) granted a temporary authorization for emergency use to Pfizer and BioNTech for their COVID-19 mRNA vaccine BNT162b2 . This is the first Emergency Use Authorization following a worldwide phase III trial of a vaccine to help fight the pandemic. Like the global population, Yourway has closely followed COVID-19 vaccine trials and is excited about the beginnings of a wider rollout of the vaccine.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Global Clinical Supplies Group (GCSG)

October 14-16, 2025
Hungary, Budapest

Schedule a Meeting

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Media

Articles

Critical Packaging and Labeling Considerations for Decentralized Clinical Trials

Open chat

Hello! How can I help you?